Buddhist Dalin Tzu Chi General Hospital
Chia Yi, Taiwan
General hospital in Taiwan
No. 二號, Minsheng Rd, Dalin Township, Chiayi County, 622
About Buddhist Dalin Tzu Chi General Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Dalin Tzu Chi General Hospital
3
Boehringer Ingelheim
2
National Taiwan University Hospital
2
Buddhist Tzu Chi General Hospital
1
National Cheng-Kung University Hospital
1
Clinical Trials at Buddhist Dalin Tzu Chi General Hospital
During the past decade, Buddhist Dalin Tzu Chi General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
2003-07-01
Completed
860
An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus
2007-03-01
2009-03-01
Unknown status
40
Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
2005-07-01
2008-06-01
Completed
42
Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load
2009-09-01
2012-12-01
Terminated
59
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT
2008-09-01
2015-05-01
Unknown status
130
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
2014-01-20
2015-12-18
Completed
422
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
2013-08-01
2016-04-01
Completed
395
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Buddhist Dalin Tzu Chi General Hospital" #1 sponsor was "Pfizer" with 4 trials, followed by "Dalin Tzu Chi General Hospital" with 3 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "National Taiwan University Hospital" with 2 trials sponsored and "Buddhist Tzu Chi General Hospital"
with 2 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Buddhist Dalin Tzu Chi General Hospital"
#1 collaborator was "National Science Council, Taiwan" with 2 trials as a collaborator, "Department of Health, Executive Yuan, R.O.C. (Taiwan)" with 1 trials as a collaborator, "Felix Leung, MD, Sepulveda Ambulatory Care Center, VAGLAHS" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Buddhist Dalin Tzu Chi General Hospital
According to Clinical.Site data, the most researched conditions in "Buddhist Dalin Tzu Chi General Hospital" are
"Hepatitis C" (2 trials), "Psoriatic Arthritis" (2 trials), "Adenoma" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Buddhist Dalin Tzu Chi General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Buddhist Dalin Tzu Chi General Hospital
Most popular intervention types in "Buddhist Dalin Tzu Chi General Hospital" are "Drug" (11 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Tofacitinib" (2 trials), "placebo" (2 trials), "Adalimumab" (1 trials) and "Air insufflation" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Buddhist Dalin Tzu Chi General Hospital
The vast majority of trials in "Buddhist Dalin Tzu Chi General Hospital" are
13 trials for "All" genders.
Clinical Trials Status at Buddhist Dalin Tzu Chi General Hospital
Currently, there are NaN active trials in "Buddhist Dalin Tzu Chi General Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Buddhist Dalin Tzu Chi General Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Buddhist Dalin Tzu Chi General Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 3 trials that are defined as “Not Applicable".